Searched for
ELI LILLY ZEPBOUND
Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...27 May, 2026, 05.30 AM IST- US Stocks: Eli Lilly raises annual forecasts as GLP-1 drugs fuel growthEli Lilly raised its annual profit and revenue forecasts and posted better-than-expected first quarter on Thursday, on steady demand for it...30 Apr, 2026, 05.17 PM IST
- Diabetes type 2, weight loss treatment can be done under single procedure? Research reveals big health updateDiabetes type 2 treatment: Trial participants either underwent a procedure used to improve blood sugar control in type 2 diabetes called du...25 Apr, 2026, 06.20 PM IST
- Eli Lilly Foundayo weight-loss pill vs Novo Nordisk Wegovy oral obesity treatment tablets: Which medicine is the most prescribed across U.S.?Eli Lilly Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started on A...17 Apr, 2026, 07.05 PM IST
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...13 Apr, 2026, 07.23 AM IST
- LLY stock jumps 9%: Why Eli Lilly stock is soaring today - Mounjaro, Zepbound sales drive massive earnings beat and 2026 forecast stuns Wall StreetLLY stock today: Eli Lilly's stock saw a significant jump following impressive fourth-quarter results and a strong 2026 financial forecast....05 Feb, 2026, 03.23 AM IST
- Eli Lilly cuts Zepbound price to widen access for obesity drugEli Lilly has reduced the cost of its popular obesity drug Zepbound for American patients. This move aims to make the treatment more access...01 Dec, 2025, 09.37 PM IST
- Eli Lilly becomes first healthcare firm to hit $1 trillion market cap - here’s why LLY stock has jumped over 36% this yearEli Lilly stock today: Eli Lilly achieved a historic milestone, briefly touching a $1 trillion market cap. This success is driven by strong...21 Nov, 2025, 09.49 PM IST
- Eli Lilly drops CVS drug plan for staff after Novo obesity deal: ReportEli Lilly is switching its employee drug benefit plan from CVS Health to Rightway, a move reportedly linked to CVS's decision to stop cover...12 Nov, 2025, 08.54 PM IST
- Eli Lilly Q2 earnings beat expectations on Mounjaro, Zepbound sales, stock falls after obesity drug trial missLilly stock latest news: Eli Lilly's Q2 earnings soared, fueled by Mounjaro and Zepbound's impressive sales, leading to raised full-year gu...07 Aug, 2025, 09.12 PM IST
- Eli Lilly announces $27-billion US expansion: To add 13,000 jobs and new manufacturing sitesEli Lilly & Co has announced a $27-billion expansion of its US manufacturing operations, adding four new sites and creating 13,000 jobs. Th...27 Feb, 2025, 01.15 AM IST
- Billionaire Philippe Laffont sold Nvidia, AMD and invested heavily in two companies dominating a market that may reach beyond $100 billion; which are the stocks?Analysts predict the weight loss drug market to grow between $100 billion and $130 billion by 2030, as per a report.01 Feb, 2025, 02.38 AM IST
- Zepbound: The new weight loss pill that’s set to beat Wegovy, according to Eli LillyEli Lilly’s Zepbound has outperformed Novo Nordisk’s Wegovy in a recent clinical trial, with patients losing more weight on average. While ...04 Dec, 2024, 09.17 PM IST
- Lilly lifts sales forecast by $3 billion as weight-loss drug powers resultsAnalysts have said the companies will likely split the U.S. market roughly 50-50 by the end of 2024, as Lilly bolsters its manufacturing ca...08 Aug, 2024, 09.20 PM IST
- Eli Lilly rises 6%; company raises 2024 sales forecast by $2 billionExplosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales...30 Apr, 2024, 08.23 PM IST
- Lilly rides wave of weight-loss drug demand, working to expand capacityShares were off about 1% at $696.82 after gaining about 11% in January, making Lilly the eighth largest company in the U.S. by market capit...07 Feb, 2024, 12.06 AM IST
- Investors increase holdings of weight-loss drug makers' shares in Q3Shares of both companies have soared this year as Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Mounjaro and Zepbound have been shown t...15 Nov, 2023, 08.01 AM IST
Load More
